The Most Common Nanostructures As a Contrast Agent in Medical Imaging

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):

Share this content! On (X network) By

The Most Common Nanostructures As a Contrast Agent in Medical Imaging Publisher

Hashemi MG¹ ; Gholami M² ; Alaei M³ ; Hashemi MG¹ ; Yazdi SNM⁵ ; Talebi V¹ ; Helali H⁶

Show Affiliations

1. Department of Radiology, Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran
2. Department of Pharmacy, Islamic Azad University Pharmaceutical Sciences Branch, Tehran, Iran
3. School of Medicine, Shahid Beheshti Medical University, Tehran, Iran
4. School of Medicine, Qazvin University of Medical Sciences, Qazvin, Iran
5. Advanced Diagnostic and Interventional Radiology Research Center (ADIR), Tehran University of Medical Sciences, Tehran, Iran
6. Department of Psychiatry, School of Medicine, Shahid Beheshti Medical University, Tehran, Iran

Source: Nanomedicine Research Journal Published:2023

Abstract

The differentiation of certain structures from nearby tissues during medical imaging requires a sufficient amount of signals from the targeted area. The limitations of conventional contrast agents prevent the possibility of quick and accurate diagnosis of some cases and cause many problems for the patients and society. However, most of these restrictions can be surpassed through the unique physico-chemical characteristic nanotechnologyology and nano structures. Nanocarriers are abled to take the role of contrast agents or even provide the efficient delivery of these agents as carriers, while the capability of nanostructures in facilitating the simultaneous transportation of diagnostic and therapeutic agents is also undeniable. Thanks to the modern application of nanotechnology, it is possible to perform the targeted distribution of diagnostic and therapeutic agents to the desired locations. The status of in vivo surveillance and targeting efficiency can be improved by exploiting the potential benefits of nanoparticles and therefore, it is quiet expected to witness interesting characteristics from nanocarrier imaging agents for the diagnosis and staging of different diseases. This work presents a summary on the most common contrast agent nanostructures in medical imaging. © 2023 Authors. All rights reserved.

Related Docs

View other Related Docs

1. An Update on Nanoparticle-Based Contrast Agents in Medical Imaging, Artificial Cells# Nanomedicine and Biotechnology (2018)

2. Superparamagnetic Iron Oxide Nanoparticles for in Vivo Molecular and Cellular Imaging, Contrast Media and Molecular Imaging (2015)

3. Nanoparticles and Targeted Drug Delivery in Cancer Therapy, Immunology Letters (2017)

4. Solid Silica Nanoparticles: Applications in Molecular Imaging, Contrast Media and Molecular Imaging (2015)

5. Targeted Superparamagnetic Iron Oxide Nanoparticles for Early Detection of Cancer: Possibilities and Challenges, Nanomedicine: Nanotechnology# Biology# and Medicine (2016)

6. Nanotechnology-Assisted Lung Cancer Diagnosis: Biomarkers and Imaging, Journal of Nanoparticle Research (2025)

7. Liposomes: Structure, Biomedical Applications, and Stability Parameters With Emphasis on Cholesterol, Frontiers in Bioengineering and Biotechnology (2021)

8. A Review on the Role of Lipid-Based Nanoparticles in Medical Diagnosis and Imaging, Therapeutic Delivery (2018)

Experts (# of related papers)

View all Related Experts

Fatemeh Atyabi (4)

Rassoul Dinarvand (3)

Other Related Docs

9. Magneto-Fluorescent Contrast Agents Based on Carbon Dots@Ferrite Nanoparticles for Tumor Imaging, Journal of Magnetism and Magnetic Materials (2022)

10. Dual Nano-Sized Contrast Agents in Pet/Mri: A Systematic Review, Contrast Media and Molecular Imaging (2016)

11. Folate-Conjugated Nanoparticles As a Potent Therapeutic Approach in Targeted Cancer Therapy, Tumor Biology (2015)

12. Evaluation of Size, Morphology, Concentration, and Surface Effect of Gold Nanoparticles on X-Ray Attenuation in Computed Tomography, Physica Medica (2018)

13. Nanotechnology in Diagnosis and Treatment of Coronary Artery Disease, Nanomedicine (2016)

14. Biomedical Applications of Superparamagnetic Nanoparticles in Molecular Scale, Current Organic Chemistry (2015)

15. On-Chip Synthesis of Fine-Tuned Bone-Seeking Hybrid Nanoparticles, Nanomedicine (2015)

16. Multimodal Cancer Cell Therapy Using Au@Fe 2 O 3 Core–Shell Nanoparticles in Combination With Photo-Thermo-Radiotherapy, Photodiagnosis and Photodynamic Therapy (2018)

17. Preparation of Methotrexate Loaded Plga Nanoparticles Coated With Pva and Poloxamer188, Nanomedicine Research Journal (2018)

18. Observation of Targeted Gold Nanoparticles in Nasopharyngeal Tumour Nude Mice Model Through Dual-Energy Computed Tomography, IET Nanobiotechnology (2021)

19. Theranostic Muc-1 Aptamer Targeted Gold Coated Superparamagnetic Iron Oxide Nanoparticles for Magnetic Resonance Imaging and Photothermal Therapy of Colon Cancer, Colloids and Surfaces B: Biointerfaces (2016)

20. Development and Physicochemical, Toxicity and Immunogenicity Assessments of Recombinant Hepatitis B Surface Antigen (Rhbsag) Entrapped in Chitosan and Mannosylated Chitosan Nanoparticles: As a Novel Vaccine Delivery System and Adjuvant, Artificial Cells# Nanomedicine and Biotechnology (2018)

21. Bio-Applications of Graphene Composites: From Bench to Clinic, Advanced 2D Materials (2016)

22. Bypassing Protein Corona Issue on Active Targeting: Zwitterionic Coatings Dictate Specific Interactions of Targeting Moieties and Cell Receptors, ACS Applied Materials and Interfaces (2016)

23. Silk Fibroin Nanoparticle As a Novel Drug Delivery System, Journal of Controlled Release (2015)

24. Stimulus-Responsive Liposomes As Smart Nanoplatforms for Drug Delivery Applications, Nanotechnology Reviews (2018)

25. Monoclonal Antibody Conjugated Magnetic Nanoparticles Could Target Muc-1-Positive Cells in Vitro But Not in Vivo, Contrast Media and Molecular Imaging (2015)

26. Development of Ga-68 Radiolabeled Dota Functionalized and Acetylated Pamam Dendrimer-Coated Iron Oxide Nanoparticles As Pet/Mr Dual-Modal Imaging Agent, International Journal of Polymeric Materials and Polymeric Biomaterials (2021)

27. Polyethylenimine-Graft-Poly (Maleic Anhydride-Alt-1-Octadecene) Coated Fe3o4 Magnetic Nanoparticles: Promising Targeted Ph-Sensitive System for Curcumin Delivery and Mr Imaging, International Journal of Polymeric Materials and Polymeric Biomaterials (2021)

28. Green Synthesis and Characterization of Biocompatible Silver Nanoparticles Using Stachys Lavandulifolia Vahl. Extract and Their Antimicrobial Performance Study, Journal of Environmental Treatment Techniques (2020)

29. Boron Neutron Capture Therapy: Moving Toward Targeted Cancer Therapy, Journal of Cancer Research and Therapeutics (2016)

30. The Use of Nanoparticles As a Promising Therapeutic Approach in Cancer Immunotherapy, Artificial Cells# Nanomedicine and Biotechnology (2016)

31. Optimization of Docetaxel Loading Conditions in Liposomes: Proposing Potential Products for Metastatic Breast Carcinoma Chemotherapy, Scientific Reports (2020)

32. Crucial Role of the Protein Corona for the Specific Targeting of Nanoparticles, Nanomedicine (2015)

33. Cancer Nanomedicine: Special Focus on Cancer Immunotherapy, Cancer Immunology: Bench to Bedside Immunotherapy of Cancers# Second Edition (2020)

34. Infection-Resistant Mri-Visible Scaffolds for Tissue Engineering Applications, BioImpacts (2016)

35. New Insights Into Designing Hybrid Nanoparticles for Lung Cancer: Diagnosis and Treatment, Journal of Controlled Release (2019)

36. Exploring Innovative Strides in Radiolabeled Nanoparticle Progress for Multimodality Cancer Imaging and Theranostic Applications, Cancer Imaging (2024)

37. Macrophage Repolarization Using Cd44-Targeting Hyaluronic Acid–Polylactide Nanoparticles Containing Curcumin, Artificial Cells# Nanomedicine and Biotechnology (2018)

38. Nanotechnology for Delivery of Gemcitabine to Treat Pancreatic Cancer, Biomedicine and Pharmacotherapy (2017)

39. Nanoliposome Encapsulated Anesthetics for Local Anesthesia Application, Biomedicine and Pharmacotherapy (2017)

40. Smart Internal Stimulus-Responsive Nanocarriers for Drug and Gene Delivery, Smart internal stimulus-responsive nanocarriers for drug and gene delivery (2015)

41. As1411 Aptamer-Anionic Linear Globular Dendrimer G2-Iohexol Selective Nano-Theranostics, Scientific Reports (2017)

Style	Citing Format
MLA	Hashemi MG, et al.. "The Most Common Nanostructures As a Contrast Agent in Medical Imaging." Nanomedicine Research Journal, vol. 8, no. 2, 2023, pp. 127-140.
APA	Hashemi MG, Gholami M, Alaei M, Hashemi MG, Yazdi SNM, Talebi V, Helali H (2023). The Most Common Nanostructures As a Contrast Agent in Medical Imaging. Nanomedicine Research Journal, 8(2), 127-140.
Chicago	Hashemi MG, Gholami M, Alaei M, Hashemi MG, Yazdi SNM, Talebi V, Helali H. "The Most Common Nanostructures As a Contrast Agent in Medical Imaging." Nanomedicine Research Journal 8, no. 2 (2023): 127-140.
Harvard	Hashemi MG et al. (2023) 'The Most Common Nanostructures As a Contrast Agent in Medical Imaging', Nanomedicine Research Journal, 8(2), pp. 127-140.
Vancouver	Hashemi MG, Gholami M, Alaei M, Hashemi MG, Yazdi SNM, Talebi V, et al.. The Most Common Nanostructures As a Contrast Agent in Medical Imaging. Nanomedicine Research Journal. 2023;8(2):127-140.
BibTex	@article{ author = {Hashemi MG and Gholami M and Alaei M and Hashemi MG and Yazdi SNM and Talebi V and Helali H}, title = {The Most Common Nanostructures As a Contrast Agent in Medical Imaging}, journal = {Nanomedicine Research Journal}, volume = {8}, number = {2}, pages = {127-140}, year = {2023} }
RIS	TY - JOUR AU - Hashemi MG AU - Gholami M AU - Alaei M AU - Hashemi MG AU - Yazdi SNM AU - Talebi V AU - Helali H TI - The Most Common Nanostructures As a Contrast Agent in Medical Imaging JO - Nanomedicine Research Journal VL - 8 IS - 2 SP - 127 EP - 140 PY - 2023 ER -

Science Communicator Platform

Authors

Authors Affiliations

Abstract